Top news of the week: 27.10.2020.
#biotechnology #biospace #lifesciences #pharmaceuticals #pandemic #opioid #opioidcrisis #biopharma #GoodDayBIO #cytokine
Companies And Industries
Be Biopharma debuts with $52M to advance engineered B-cell therapies https://t.co/F4TGwWiZDc https://t.co/46VwctXHPt
OpenBe Biopharma debuts with $52M to advance engineered B-cell therapies
You may have heard of T cells before, but Aleks Radovic-Moreno, Be Biopharma’s co-founder, president and director, is betting on B cells as the future of cell therapies.
Ex-Medivation, Axovant David Hung’s cancer startup Nuvation Bio agrees merger with blank cheque firm Panacea $PANA that will take it public and provide $850m in funding https://t.co/XYqPsRGbTR
OpenDavid Hung’s Nuvation Bio seals merger with blank cheque firm Panacea
Two years after quietly forming cancer start-up Nuvation Bio, ex-Axovant and Medivation CEO David Hung has agreed a
How the Biopharma Industry is Tackling the Opioid Crisis
#biospace #lifesciences #biotechnology #pharmaceuticals #biopharma #opioid #opioidcrisis
https://t.co/GKFnQ9WUK8
OpenHow the Biopharma Industry is Tackling the Opioid Crisis
Many drug makers are investing in new science and hope to transition pain therapy approaches away from synthetic opioids. Biospace has tracked a few key alternative therapeutic candidates.
Be Biopharma launches with a $52M series A to develop engineered B-cell medicines https://t.co/a64BT2Qa38
OpenBe Biopharma launches with a $52M series A to develop engineered B-cell medicines
Be Biopharma Inc. is looking to develop engineered B cells to treat a wide range of diseases. The new category of cellular medicine is based on the work of David Rawlings and Richard James, ...
RT @venture_center: An exciting certificate course in #biopharmaceuticals coming up, starting on 30th Oct. Attend and get yourself Industry ready. Register here: https://t.co/PETSNxxdbC
@aparanjape https://t.co/xquAcRp67y
Open(30 Oct - 19 Dec 2020) Biopharma 101: Analytical Characterization of Biopharmaceuticals
Biopharma 101: Analytical Characterization of Biopharmaceuticals -Organized by Center for BioPharma Analysis at Venture Center - Total duration: 6 weeks | Every Friday - Saturday| 1600 – ...
#GoodDayBIO: Led by @jmaxlevin of @OvidRx, 9 biotech CEOs signed a letter supporting public health experts. Recycling isn’t the only solution to the plastic problem – we need to embrace sustainable innovation like @Virent_Inc and @danimersci's bioplastics. https://t.co/6SggFmZ3Re
OpenThe ‘United Armed Forces’ against COVID-19
Closing the week with a call for support for scientists—as well as a look at why recycling isn’t the only solution to the plastic problem. (You should still recycle, though.) Here are ...
Research Roundup: Predicting COVID-19 Cytokine Storm and More
#biospace #lifesciences #biotechnology #pharmaceuticals #researchroundup #cytokine
#COVID-19 #coronavirus #pandemic #COVID19
https://t.co/YktyX7sF11
OpenResearch Roundup: Predicting COVID-19 Cytokine Storm and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Special report: The 20 most influential people in the fight against COVID-19 https://t.co/ZzcOgn70HN
OpenThe 20 most influential people in the fight against COVID-19
For the pharma world, the pandemic has been a crisis with a purpose. Scientists, regulators, biotech companies and drugmakers large and small have taken center stage as they hunt for drugs, ...